Insurance data can help fill gaps between longer medical trials for patients up against the clock

Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
ABC4 Utah

New Intermountain Health Study finds targeted Vitamin D3 supplementation cuts risk of heart attack patients having a second heart attack in half

A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their risk of a second heart attack, a new ...

Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of OLN324 Compared to Faricimab (Vabysmo®) i…

Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases ...
MedPage Today on MSN

Opportunistic Cholesterol Gene Screens: Good in Theory Only?

The ROAR trial tested the hypothesis that returning familial hypercholesterolemia-associated genetic results leads to ...
Science Daily

Why your vitamin D supplements might not be working

A randomized trial from Vanderbilt-Ingram Cancer Center reveals that magnesium may be the missing key to keeping vitamin D ...
Lupus Foundation of America

Phase 2b JASMINE trial of nipocalimab demonstrates positive results for treatment of systemic lupus erythematosus

Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug ...
Clinical Trials Arena on MSN

Ascletis receives FDA approval for diabetes mellitus clinical trial of ASC30

Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...